Market Cap 242.77M
Revenue (ttm) 201.32M
Net Income (ttm) -20.92M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -10.39%
Debt to Equity Ratio 1.51
Volume 1,111,900
Avg Vol 1,191,582
Day's Range N/A - N/A
Shares Out 191.16M
Stochastic %K 7%
Beta 1.55
Analysts Strong Sell
Price Target $4.67

Company Profile

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets an...

Industry: Medical Devices
Sector: Healthcare
Phone: 925 288 6000
Address:
1220 Concord Avenue, Suite 600, Concord, United States
Amcollins711
Amcollins711 Aug. 3 at 5:53 PM
Checking out upcoming earnings for next week and a few on my radar are $CHGG $CERS $STKS and oddly $LESL interestingly 3/4 of these had recent buying activity from Y Intercept Ltd. - All transactions dated 8/1....
1 · Reply
BeefStewart
BeefStewart Aug. 3 at 4:54 PM
0 · Reply
2019Vtrader2025
2019Vtrader2025 Aug. 2 at 1:53 PM
$CERS $PACB took position in both Woods penny biotech penny trades
1 · Reply
BeefStewart
BeefStewart Aug. 1 at 7:07 PM
$CERS trading near 52 week (all time?) lows...
0 · Reply
BeefStewart
BeefStewart Aug. 1 at 2:29 PM
$CERS It's possible that blood supply and demand are negatively impacted by a bad economy (less elective surgeries and perhaps less donors able or willing to donate for free if at all). BUT, there are other factors ChatGPT response below: --- 🔺 Factors that help sustain or increase blood demand in a bad economy: Essential Surgeries and Emergencies Continue Trauma cases, childbirth complications, and emergency surgeries still require blood, regardless of economic conditions. Chronic Conditions Persist Patients with conditions like cancer, sickle cell disease, and anemia continue to need transfusions. Aging Populations In many developed countries, aging demographics maintain high blood usage, unaffected by economic cycles. Reduced Donations, Not Reduced Demand In recessions, blood supply often drops (fewer donors, fewer drives), but demand can stay stable or even become harder to meet due to this mismatch. --- So the challenge would be supply more than demand.
1 · Reply
BeefStewart
BeefStewart Aug. 1 at 1:58 PM
$CERS While it's too early to draw any conclusions, I am just pleasantly surprised to see this even slightly green on a terrible day for the markets.
1 · Reply
BeefStewart
BeefStewart Aug. 1 at 1:13 PM
$CERS If things were logical, this would be a strong stock to buy in a terrible market on account of its products having inelastic demand and its customers signing longterm contracts, as far as I understand. Just my opinion, of course.
0 · Reply
BeefStewart
BeefStewart Jul. 31 at 11:10 PM
$CERS Any predictions for earnings?
1 · Reply
BeefStewart
BeefStewart Jul. 31 at 5:23 PM
0 · Reply
BeefStewart
BeefStewart Jul. 31 at 1:53 PM
$CERS How it feels hoping people will buy this stock:
1 · Reply
Latest News on CERS
Cerus Corporation Celebrates World Blood Donor Day 2025

Jun 13, 2025, 4:01 PM EDT - 7 weeks ago

Cerus Corporation Celebrates World Blood Donor Day 2025


Cerus Corporation (CERS) Q1 2025 Earnings Call Transcript

May 1, 2025, 8:26 PM EDT - 3 months ago

Cerus Corporation (CERS) Q1 2025 Earnings Call Transcript


Cerus Corporation (CERS) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 9:50 PM EST - 5 months ago

Cerus Corporation (CERS) Q4 2024 Earnings Call Transcript


Cerus Corporation (CERS) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 11:52 PM EDT - 9 months ago

Cerus Corporation (CERS) Q3 2024 Earnings Call Transcript


Cerus Corporation Announces Third Quarter 2024 Financial Results

Oct 30, 2024, 4:00 PM EDT - 9 months ago

Cerus Corporation Announces Third Quarter 2024 Financial Results


Cerus Corporation (CERS) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 8:29 PM EDT - 1 year ago

Cerus Corporation (CERS) Q2 2024 Earnings Call Transcript


Cerus Corporation Celebrates World Blood Donor Day 2024

Jun 14, 2024, 8:30 AM EDT - 1 year ago

Cerus Corporation Celebrates World Blood Donor Day 2024


Cerus Corporation (CERS) Q1 2024 Earnings Call Transcript

May 2, 2024, 7:37 PM EDT - 1 year ago

Cerus Corporation (CERS) Q1 2024 Earnings Call Transcript


Cerus Corporation (CERS) Q4 2023 Earnings Call Transcript

Mar 5, 2024, 6:43 PM EST - 1 year ago

Cerus Corporation (CERS) Q4 2023 Earnings Call Transcript


Cerus Corporation (CERS) Q3 2023 Earnings Call Transcript

Nov 2, 2023, 10:52 PM EDT - 1 year ago

Cerus Corporation (CERS) Q3 2023 Earnings Call Transcript


Cerus Corporation Celebrates World Blood Donor Day 2023

Jun 14, 2023, 8:30 AM EDT - 2 years ago

Cerus Corporation Celebrates World Blood Donor Day 2023


Amcollins711
Amcollins711 Aug. 3 at 5:53 PM
Checking out upcoming earnings for next week and a few on my radar are $CHGG $CERS $STKS and oddly $LESL interestingly 3/4 of these had recent buying activity from Y Intercept Ltd. - All transactions dated 8/1....
1 · Reply
BeefStewart
BeefStewart Aug. 3 at 4:54 PM
0 · Reply
2019Vtrader2025
2019Vtrader2025 Aug. 2 at 1:53 PM
$CERS $PACB took position in both Woods penny biotech penny trades
1 · Reply
BeefStewart
BeefStewart Aug. 1 at 7:07 PM
$CERS trading near 52 week (all time?) lows...
0 · Reply
BeefStewart
BeefStewart Aug. 1 at 2:29 PM
$CERS It's possible that blood supply and demand are negatively impacted by a bad economy (less elective surgeries and perhaps less donors able or willing to donate for free if at all). BUT, there are other factors ChatGPT response below: --- 🔺 Factors that help sustain or increase blood demand in a bad economy: Essential Surgeries and Emergencies Continue Trauma cases, childbirth complications, and emergency surgeries still require blood, regardless of economic conditions. Chronic Conditions Persist Patients with conditions like cancer, sickle cell disease, and anemia continue to need transfusions. Aging Populations In many developed countries, aging demographics maintain high blood usage, unaffected by economic cycles. Reduced Donations, Not Reduced Demand In recessions, blood supply often drops (fewer donors, fewer drives), but demand can stay stable or even become harder to meet due to this mismatch. --- So the challenge would be supply more than demand.
1 · Reply
BeefStewart
BeefStewart Aug. 1 at 1:58 PM
$CERS While it's too early to draw any conclusions, I am just pleasantly surprised to see this even slightly green on a terrible day for the markets.
1 · Reply
BeefStewart
BeefStewart Aug. 1 at 1:13 PM
$CERS If things were logical, this would be a strong stock to buy in a terrible market on account of its products having inelastic demand and its customers signing longterm contracts, as far as I understand. Just my opinion, of course.
0 · Reply
BeefStewart
BeefStewart Jul. 31 at 11:10 PM
$CERS Any predictions for earnings?
1 · Reply
BeefStewart
BeefStewart Jul. 31 at 5:23 PM
0 · Reply
BeefStewart
BeefStewart Jul. 31 at 1:53 PM
$CERS How it feels hoping people will buy this stock:
1 · Reply
BeefStewart
BeefStewart Jul. 30 at 8:22 PM
$CERS Is anyone still here?
2 · Reply
BeefStewart
BeefStewart Jul. 30 at 8:13 PM
$CERS Not every investment works out. I hope this will turnaround, but damn this is looking bad. Hopefully it jumps on ER next Tuesday after hours.
0 · Reply
BeefStewart
BeefStewart Jul. 30 at 7:13 PM
$CERS looks like a purchase of over 100k shares caused the bid/ask to rise a penny...
0 · Reply
BeefStewart
BeefStewart Jul. 30 at 6:52 PM
$CERS sad
0 · Reply
BeefStewart
BeefStewart Jul. 30 at 3:21 PM
$CERS It seems that it peaks in the morning and then fades...
0 · Reply
BeefStewart
BeefStewart Jul. 30 at 2:29 PM
0 · Reply
BeefStewart
BeefStewart Jul. 29 at 8:39 PM
0 · Reply
BeefStewart
BeefStewart Jul. 29 at 7:05 PM
$CERS Is @BioGem still here?
0 · Reply
BeefStewart
BeefStewart Jul. 29 at 6:28 PM
$CERS looks like a solid buy of 70k+ shares, I think.
3 · Reply
BeefStewart
BeefStewart Jul. 29 at 6:22 PM
$CERS a sad 2 days for this stock...
0 · Reply
BeefStewart
BeefStewart Jul. 29 at 4:24 PM
$CERS added at 1.33 yolo
0 · Reply
BeefStewart
BeefStewart Jul. 29 at 4:09 PM
0 · Reply